The global drug delivery devices market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing number of patients suffering from chronic diseases and the rising demand for minimally invasive procedures. In addition, technological advancements in drug delivery devices are also driving the growth of this market.
Injection type segment accounted for more than one-third share in 2017 and is expected to maintain its dominance throughout the forecast period due to its high adoption rate among pharmaceutical companies and hospitals. Mucosal type segment accounted for more than one-fifth share in 2017 and is expected to grow at a CAGR of 6% during the forecast period due to its high adoption rate among clinics as well as pharmaceutical companies. Implanted type segment accounted for less than one-tenth share in 2017 but it is expected that it will grow at a CAGR of 7% during the forecast period due to its high adoption rate among hospitals as well as clinics.
Some Of The Growth Factors Of This Market:
- The rising geriatric population base is also expected to fuel the growth of this market over the forecast period owing to their increased susceptibility towards chronic diseases and higher incidence rates of these conditions as compared with younger populations.
- Increasing awareness about various types of drugs and their benefits among consumers has led them to adopt these products more frequently than before, which in turn has boosted demand for drug delivery devices globally over the past few years . This trend is anticipated to continue during the forecast period owing to growing consumer awareness about various types of drugs and their benefits among consumers globally over the past few years. This trend is anticipated t o continue during th eforecast period owing t ogrowing consumer awareness about various types ot drugs an dtheir benefits am ongconsumers glob allyoverthepastfewyears.
Industry Growth Insights published a new data on “Drug Delivery Devices Market”. The research report is titled “Drug Delivery Devices Market research by Types (Injection type, Mucosal type, Implanted type, Others type), By Applications (Pharmaceutical companies, Hospitals, Clinics, Other), By Players/Companies Cipla, Baxter International, Nipro Corporation, Roche, Boehringer Ingelheim, Allergan, 3M, BD, Catalent, Bausch Health, Bayer AG, Chiesi, Phillips-Medisize, Johnson & Johnson, Shandong Weigao, Pfizer, B.Braun, Novartis AG, Zhengkang, Gerresheimer, COVIDIEN Medtronic, Schott forma vitrum, Alkermes, Skyepharma”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Drug Delivery Devices Market Research Report
By Type
Injection type, Mucosal type, Implanted type, Others type
By Application
Pharmaceutical companies, Hospitals, Clinics, Other
By Companies
Cipla, Baxter International, Nipro Corporation, Roche, Boehringer Ingelheim, Allergan, 3M, BD, Catalent, Bausch Health, Bayer AG, Chiesi, Phillips-Medisize, Johnson & Johnson, Shandong Weigao, Pfizer, B.Braun, Novartis AG, Zhengkang, Gerresheimer, COVIDIEN Medtronic, Schott forma vitrum, Alkermes, Skyepharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Drug Delivery Devices Market Report Segments:
The global Drug Delivery Devices market is segmented on the basis of:
Types
Injection type, Mucosal type, Implanted type, Others type
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical companies, Hospitals, Clinics, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Cipla
- Baxter International
- Nipro Corporation
- Roche
- Boehringer Ingelheim
- Allergan
- 3M
- BD
- Catalent
- Bausch Health
- Bayer AG
- Chiesi
- Phillips-Medisize
- Johnson & Johnson
- Shandong Weigao
- Pfizer
- B.Braun
- Novartis AG
- Zhengkang
- Gerresheimer
- COVIDIEN Medtronic
- Schott forma vitrum
- Alkermes
- Skyepharma
Highlights of The Drug Delivery Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Injection type
- Mucosal type
- Implanted type
- Others type
- By Application:
- Pharmaceutical companies
- Hospitals
- Clinics
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Drug Delivery Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Drug delivery devices are medical devices that help to improve the effectiveness of medications by speeding up their absorption into the body. Devices can be inserted under the skin, injected directly into a vein, or swallowed.
Some of the major players in the drug delivery devices market are Cipla, Baxter International, Nipro Corporation, Roche, Boehringer Ingelheim, Allergan, 3M, BD, Catalent, Bausch Health, Bayer AG, Chiesi, Phillips-Medisize, Johnson & Johnson, Shandong Weigao, Pfizer, B.Braun, Novartis AG, Zhengkang, Gerresheimer, COVIDIEN Medtronic, Schott forma vitrum, Alkermes, Skyepharma.
The drug delivery devices market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Drug Delivery Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Drug Delivery Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Drug Delivery Devices Market - Supply Chain
4.5. Global Drug Delivery Devices Market Forecast
4.5.1. Drug Delivery Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Drug Delivery Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Drug Delivery Devices Market Absolute $ Opportunity
5. Global Drug Delivery Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Drug Delivery Devices Market Size and Volume Forecast by Type
5.3.1. Injection type
5.3.2. Mucosal type
5.3.3. Implanted type
5.3.4. Others type
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Drug Delivery Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Drug Delivery Devices Market Size and Volume Forecast by Application
6.3.1. Pharmaceutical companies
6.3.2. Hospitals
6.3.3. Clinics
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Drug Delivery Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Drug Delivery Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Drug Delivery Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Drug Delivery Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Drug Delivery Devices Demand Share Forecast, 2019-2026
9. North America Drug Delivery Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Drug Delivery Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Drug Delivery Devices Market Size and Volume Forecast by Application
9.4.1. Pharmaceutical companies
9.4.2. Hospitals
9.4.3. Clinics
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Drug Delivery Devices Market Size and Volume Forecast by Type
9.7.1. Injection type
9.7.2. Mucosal type
9.7.3. Implanted type
9.7.4. Others type
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Drug Delivery Devices Demand Share Forecast, 2019-2026
10. Latin America Drug Delivery Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Drug Delivery Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Drug Delivery Devices Market Size and Volume Forecast by Application
10.4.1. Pharmaceutical companies
10.4.2. Hospitals
10.4.3. Clinics
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Drug Delivery Devices Market Size and Volume Forecast by Type
10.7.1. Injection type
10.7.2. Mucosal type
10.7.3. Implanted type
10.7.4. Others type
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Drug Delivery Devices Demand Share Forecast, 2019-2026
11. Europe Drug Delivery Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Drug Delivery Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Drug Delivery Devices Market Size and Volume Forecast by Application
11.4.1. Pharmaceutical companies
11.4.2. Hospitals
11.4.3. Clinics
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Drug Delivery Devices Market Size and Volume Forecast by Type
11.7.1. Injection type
11.7.2. Mucosal type
11.7.3. Implanted type
11.7.4. Others type
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Drug Delivery Devices Demand Share, 2019-2026
12. Asia Pacific Drug Delivery Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Drug Delivery Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Drug Delivery Devices Market Size and Volume Forecast by Application
12.4.1. Pharmaceutical companies
12.4.2. Hospitals
12.4.3. Clinics
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Drug Delivery Devices Market Size and Volume Forecast by Type
12.7.1. Injection type
12.7.2. Mucosal type
12.7.3. Implanted type
12.7.4. Others type
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Drug Delivery Devices Demand Share, 2019-2026
13. Middle East & Africa Drug Delivery Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Drug Delivery Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Drug Delivery Devices Market Size and Volume Forecast by Application
13.4.1. Pharmaceutical companies
13.4.2. Hospitals
13.4.3. Clinics
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Drug Delivery Devices Market Size and Volume Forecast by Type
13.7.1. Injection type
13.7.2. Mucosal type
13.7.3. Implanted type
13.7.4. Others type
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Drug Delivery Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Drug Delivery Devices Market: Market Share Analysis
14.2. Drug Delivery Devices Distributors and Customers
14.3. Drug Delivery Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Cipla
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Baxter International
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Nipro Corporation
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Roche
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Boehringer Ingelheim
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Allergan
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. 3M
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. BD
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Catalent
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Bausch Health
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Bayer AG
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Chiesi
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Phillips-Medisize
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Johnson & Johnson
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Shandong Weigao
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Pfizer
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. B.Braun
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Novartis AG
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. Zhengkang
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. Gerresheimer
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
